Indicated for: bone disorders
Route of administration: implantation
Substance: eptotermin alfa (growth hormone)
ATC: M05BC02 (Musculo-skeletal system | Drugs affecting bone structure and mineralization | Bone morphogenetic proteins)
Eptotermin alfa is a biological medication used for the treatment of malignant pleural effusion, an accumulation of fluid in the pleural cavity caused by cancer. It works by stimulating a controlled inflammatory reaction, which causes the pleural layers to adhere and prevents the recurrence of fluid accumulation.
Eptotermin alfa is administered by direct instillation into the pleural cavity under specialized medical supervision, usually in a hospital. The dose and frequency of treatment are determined individually, depending on the patient's response.
Side effects may include fever, chest pain, local reactions, or, rarely, severe allergic reactions. Careful monitoring is necessary throughout the procedure.
Eptotermin alfa is an effective option for managing malignant pleural effusion, helping to reduce symptoms and improve the quality of life for patients with advanced oncological conditions.